Follow
Wenyan Jiang
Wenyan Jiang
Assistant Professor, Mount Sinai School of Medicine, Columbia University, Rockefeller University
Verified email at mssm.edu - Homepage
Title
Cited by
Cited by
Year
Multiplex genome engineering using CRISPR/Cas systems
L Cong, FA Ran, D Cox, S Lin, R Barretto, N Habib, PD Hsu, X Wu, ...
Science 339 (6121), 819-823, 2013
177632013
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
W Jiang, D Bikard, D Cox, F Zhang, LA Marraffini
Nature biotechnology 31 (3), 233-239, 2013
29842013
Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system
D Bikard, W Jiang, P Samai, A Hochschild, F Zhang, LA Marraffini
Nucleic acids research 41 (15), 7429-7437, 2013
13442013
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
D Bikard, CW Euler, W Jiang, PM Nussenzweig, GW Goldberg, X Duportet, ...
Nature biotechnology 32 (11), 1146-1150, 2014
9112014
Co-transcriptional DNA and RNA cleavage during type III CRISPR-Cas immunity
P Samai, N Pyenson, W Jiang, GW Goldberg, A Hatoum-Aslan, ...
Cell 161 (5), 1164-1174, 2015
4682015
Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting
GW Goldberg, W Jiang, D Bikard, LA Marraffini
Nature 514 (7524), 633-637, 2014
2942014
Crispr-cas component systems, methods and compositions for sequence manipulation
F Zhang, L Cong, DBT Cox, P Hsu, LIN Shuailiang, RAN Fei, RJ Platt, ...
US Patent App. 14/105,035, 2014
2672014
Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids
W Jiang, I Maniv, F Arain, Y Wang, BR Levin, LA Marraffini
PLoS genetics 9 (9), e1003844, 2013
2512013
CRISPR-Cas: new tools for genetic manipulations from bacterial immunity systems
W Jiang, LA Marraffini
Annual review of microbiology 69, 209-228, 2015
2352015
Degradation of phage transcripts by CRISPR-associated RNases enables type III CRISPR-Cas immunity
W Jiang, P Samai, LA Marraffini
Cell 164 (4), 710-721, 2016
2212016
Crispr-cas component systems, methods and compositions for sequence manipulation
F Zhang, DBT Cox, L Marraffini, DO Bikard, W Jiang
US Patent App. 14/497,627, 2015
2212015
Crispr-cas component systems, methods and compositions for sequence manipulation
F Zhang, DO BIKARD, L Cong, DBT Cox, P Hsu, W Jiang, LIN Shauiliang, ...
2192014
CRISPR–Cas systems exploit viral DNA injection to establish and maintain adaptive immunity
JW Modell, W Jiang, LA Marraffini
Nature 544 (7648), 101-104, 2017
1532017
Prokaryotic single-cell RNA sequencing by in situ combinatorial indexing
SB Blattman, W Jiang, P Oikonomou, S Tavazoie
Nature microbiology 5 (10), 1192-1201, 2020
1342020
A ruler protein in a complex for antiviral defense determines the length of small interfering CRISPR RNAs
A Hatoum-Aslan, P Samai, I Maniv, W Jiang, LA Marraffini
Journal of Biological Chemistry 288 (39), 27888-27897, 2013
1332013
Crispr-cas component systems, methods and compositions for sequence manipulation
F Zhang, DBT Cox, L Marraffini, DO Bikard, W Jiang, NE Sanjana
US Patent App. 15/887,377, 2018
1272018
CRISPR-assisted editing of bacterial genomes
W Jiang, D Bikard, D Cox, F Zhang, LA Marraffini
Nature biotechnology 31 (3), 233, 2013
1222013
Development of sequence-specific antimicrobials based on programmable CRISPR-Cas nucleases
D Bikard, C Euler, W Jiang, PM Nussenzweig, GW Goldberg, X Duportet, ...
Nature biotechnology 32 (11), 1146, 2014
632014
Impact of different target sequences on type III CRISPR-Cas immunity
I Maniv, W Jiang, D Bikard, LA Marraffini
Journal of bacteriology 198 (6), 941-950, 2016
542016
Incomplete prophage tolerance by type III-A CRISPR-Cas systems reduces the fitness of lysogenic hosts
GW Goldberg, EA McMillan, A Varble, JW Modell, P Samai, W Jiang, ...
Nature communications 9 (1), 61, 2018
402018
The system can't perform the operation now. Try again later.
Articles 1–20